Company intelligence / Profile preview

Aixelo

Cambridge, Massachusetts, United Statesaixelo.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Aixelo is an active technology company based in Cambridge, Massachusetts, providing enterprise software and consulting services that integrate next-generation artificial intelligence into the R&D processes of chemical and materials companies. Their AI platform is designed to accelerate product development by generating new data on the fly, optimizing experimental design with closed-loop algorithms, and enabling seamless integration into existing laboratory workflows. The company’s focus is on improving lab productivity and innovation through accessible AI tools tailored for non-expert users[1][2][4].

Industry: Drug Discovery Services

Partnerships

No major pharmaceutical or biotech partnerships are listed; previous leadership experience includes partnerships at Kebotix[1].

Beyond the preview

Go deeper on Aixelo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aixelo.

Explore the full profile